이벤트

모두 보기
    Join BIOCYTOGEN at NIH Research Festival

    Join BIOCYTOGEN at NIH Research Festival

    September 09, 2025
    ~에 공유:

    Biocytogen is happy to announce that we will be attending the Research Festival at NIH in Bethesda, MD, on September 9th-12th! As active contributors to biomedical research, Biocytogen looks forward to bringing together fellow scientists, industry professionals, and professional researchers to this insightful event. Join us to exchange ideas and grasp new opportunities together. 

    What is the NIH Research Festival? 

    The NIH Research Festival is an annual event hosted by the National Institutes of Health (NIH) that celebrates and showcases the diverse research orchestrated  by the NIH's intramural research program. The festival includes special lectures, poster sessions, enticing workshops and a Green Labs Fair – offering an opportunity for NIH scientists, industry professionals, and academic researchers to share their work, foster collaboration, and discover latest advancements in biomedical research. The event covers a wide range of topics, and often includes presentations by leading scientists. It acts as a central platform for innovation, collaboration, and networking among professionals committed to advancing human health through scientific research. 

    Event Overview  

    Date: September 9th-12th, 2025

    Venue: NIH Bethesda campus Building 10, 9000 Rockville Pike, Bethesda, MD 20892

    Event Schedule

    For more event information, please refer to NIH Research Festival 

    About BIOCYTOGEN

    Biocytogen is a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies. Founded on gene editing technology, Biocytogen leverages genetically engineered proprietary RenMice® platforms for fully human monoclonal antibody discovery, and has established a sub-brand, RenBiologics™, to explore global partnerships for an off-the-shelf library of >400,000 fully human antibody sequences against approximately 1000 targets for worldwide collaboration. Biocytogen pioneered the generation of drug target knock-in humanized models for preclinical research, and currently provides a few thousand off-the-shelf animal and cell models under the company's sub-brand, BioMice™, along with preclinical pharmacology and gene-editing services for clients worldwide. Headquartered in Beijing, Biocytogen has branches in China (Haimen Jiangsu, Shanghai), USA(Boston, San Francisco), and Germany (Heidelberg).

    We look forward to seeing you at the NIH Research Festival at Bethesda!